Boehringer Ingelheim donates 75,000 doses of rabies vaccine
This significant rabies vaccine donation will support GARC’s efforts to address deaths due to rabies in Madagascar.
Search
Supporting Fundappas
Supporting Fundappas in Uruguay to improve quality of life of dogs and people.
More Than Scleroderma
A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Stem cells a new frontier
Stem cells may be a game changer for the development of new veterinary treatments. Read this story to find out why.
About Office Hours
Boehringer Ingelheim Office Hours mentors early-stage life-science companies providing access to expertise, an industry perspective and feedback.
GARC Louis Nel interview on global rabies control
GARC’s Executive Director Professor Louis Nel shares what it takes to fight rabies.
View from Both Sides of the Table
Scott DeWire, US Head of BD&L shares experiences that have taught him first-hand the foundations of successful partnerships
Innovation in medicinal chemistry
Darryl McConnell, Senior Vice President and Research Site Head, Austria and Jürgen Mack, Vice-President, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. We explore the potential for novel treatments and vaccines based on new knowledge and technology.
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future
Europe’s Largest Initiative Launches to Accelerate Therapy Development for COVID-19 and Future Coronavirus Threats
Acute Ischaemic Stroke
Acute Ischaemic Stroke
Improving Access to Healthcare
According to the UN Sustainable Development Goals, almost half of the global population is not covered by essential health services.
COVID-19 Supply Chain and Production
COVID
SIRPα Cancer Immunology Research
Boehringer Ingelheim scientists are investigating a new target in the innate immune system - signal-regulating protein alpha or SIRPα.
Our Curiosity Never Stops
Dr. Cornelia Dorner-Ciossek shares her thoughts on the future of brain disease research.
Generalized pustular psoriasis at EADV
Dr. Emmanuelle Clerisme-Beaty reflects on the latest developments for generalized pustular psoriasis at this year’s virtual EADV congress
The little things
In 2009 Anna was diagnosed with scleroderma. For her, however, the disease is no reason to give up. On the contrary.
Fighting against rabies in Nepal
Read about a pilot project of a critical importance which aims to raise awareness and knowledge of rabies in Nepal.
Diabetes dog symptoms chronic disease management
Learn about the symptoms of canine diabetes and how to manage the disease.
Harold and Dorothy – Full Story
T2D and CVD animation the full story – learn about the relationship between type 2 diabetes and cardiovascular disease
Our products for COPD
Our products for COPD
Boehringer Ingelheim Opens New Scientific Office in Kenya as Part of its Commitment to Improve Human and Animal Health in Africa
Boehringer Ingelheim has officially opened its new scientific office in Nairobi, Kenya.
Bees and biodiversity
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees.
Our Innovation Strategy
Our discovery research strategy is designed to sustain our track record of innovation and look for new and breakthrough medicines.
Respiratory Diseases
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.